top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Business Wire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology
From Natera, Inc.
Via Business Wire
Tickers NTRA
News headline image
Aulos Bioscience Reports Positive Phase 2 Data for Imneskibart in Doublet Checkpoint Inhibitor-Refractory Metastatic Melanoma at 2026 ASCO Annual Meeting
From Aulos Bioscience
Via Business Wire
News headline image
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
News headline image
Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline
From Bristol Myers Squibb
Via Business Wire
Tickers BMY
News headline image
Agendia to Present New FLEX Study Data at ASCO 2026 Supporting NCCN Clinical Practice Guidelines in Oncology Update Recognizing MammaPrint for Guiding Anthracycline Use in Early-Stage Breast Cancer
From Agendia, Inc.
Via Business Wire
News headline image
Obsidian Therapeutics to Present Phase 2 Clinical Data for OBX-115 in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting
From Obsidian Therapeutics, Inc.
Via Business Wire
News headline image
Dell Technologies to Present at Investor Conference in June
From Dell Technologies
Via Business Wire
Tickers DELL
News headline image
858 Therapeutics Announces Initial Data from First-in-Human Phase 1/2 Trial of PARG Inhibitor ETX-19477 to be Presented at 2026 ASCO Annual Meeting
From 858 Therapeutics
Via Business Wire
News headline image
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026
From Agenus Inc.
Via Business Wire
Tickers AGEN
News headline image
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress
From Genmab A/S
Via Business Wire
Tickers GMAB
News headline image
New ASCO and EHA 2026 Data Demonstrate Gilead and Kite’s Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology
From Gilead Sciences, Inc.
Via Business Wire
Tickers GILD
News headline image
Artera Presents Multiple ASCO 2026 Abstracts on Multimodal AI (MMAI) Risk Stratification and Treatment Decisions in Cancer
From Artera
Via Business Wire
News headline image
A2 Biotherapeutics Presents Safety and Efficacy Data from the EVEREST-2 Clinical Study, Including Update on the First Complete Response to CAR T-Cell Therapy in a Patient with Non-Small Cell Lung Cancer
From A2 Biotherapeutics, Inc.
Via Business Wire
News headline image
Convergent Therapeutics to Present Largest Set of Prospective Phase 2 Data for an Alpha Radiopharmaceutical in Lu-PSMA-Exposed Metastatic Castration-Resistant Prostate Cancer at ASCO 2026
From Convergent Therapeutics Inc.
Via Business Wire
News headline image
City of Hope Researchers Present Advances in Targeted Therapies, Microbiome Science and Blood Cancers at ASCO 2026
From City of Hope
Via Business Wire
News headline image
Flatiron Health Brings 25+ Research Acceptances and Next-Generation Capabilities to ASCO 2026
From Flatiron Health
Via Business Wire
News headline image
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)
From Ingenia Therapeutics
Via Business Wire
News headline image
Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types
From Exelixis, Inc.
Via Business Wire
Tickers EXEL
News headline image
Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
From Agenus Inc.
Via Business Wire
Tickers AGEN
News headline image
Investor Notice: Robbins LLP Informs Investors of the Veritone, Inc. Class Action
From Robbins LLP
Via Business Wire
Tickers VERI
News headline image
PINS Deadline: Rosen Law Firm Urges Pinterest, Inc. (NYSE: PINS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers PINS
News headline image
Daytona International Speedway to Install State-of-the-Art Musco LED Lighting System, Setting New Global Standard for Motorsports Venues
From Musco
Via Business Wire
News headline image
Mayville Engineering Company Announces Closing of Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares of Common Stock
From Mayville Engineering Company
Via Business Wire
Tickers MEC
News headline image
Hour Children and Mental Health Innovations Teams Win Morgan Stanley’s 2026 Strategy Challenge Supporting Nonprofits in the U.S. and the UK
From Morgan Stanley
Via Business Wire
Tickers MS
News headline image
Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Ortho Summit Featuring Digital Orthodontic Solutions Focused on Clinical Indications and Upcoming Align Innovations
From Align Technology, Inc.
Via Business Wire
Tickers ALGN
News headline image
Matador Resources Company Announces Successful Acquisitions in Federal Lease Sale
From Matador Resources Company
Via Business Wire
Tickers MTDR
News headline image
VERI CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Veritone, Inc. Investors
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
Tickers VERI
News headline image
GitLab 19.0 Extends Intelligent Orchestration to Close the Gap Between Writing Code and Shipping It
From GitLab Inc.
Via Business Wire
Tickers GTLB
News headline image
Falcon’s Beyond Lists Series B Preferred Stock on Nasdaq
From Falcon’s Beyond Global, Inc.
Via Business Wire
Tickers FBYD
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page